LETTER TO THE EDITOR Performance of the ViroSeq® HIV-1 Genotyping System v2.0 in Central Africa

Resistance genotypes in pol gene of HIV-1 were obtained by the ViroSeq(®) HIV-1 Genotyping System v2.0 (Celera Diagnostics, Alameda, CA, USA) in 138 of 145 (95%) antiretroviral treatment-experienced adults in virological failure living in Central Africa (Cameroon, Central African Republic, Chad, Gab...

Descripción completa

Detalles Bibliográficos
Autores principales: Mouafo, Linda Chapdeleine Mekue, Péré, Hélène, Ndjoyi-Mbiguino, Angélique, Koyalta, Donato, Longo, Jean De Dieu, Mbopi-Kéou, François-Xavier, Kane, Coumba Toure, Bélec, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Open 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353127/
https://www.ncbi.nlm.nih.gov/pubmed/25767633
http://dx.doi.org/10.2174/1874613601509010009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353127/
https://www.ncbi.nlm.nih.gov/pubmed/25767633
http://dx.doi.org/10.2174/1874613601509010009

Ejemplares similares